Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01622088
Brief Title: Phase 3 Extension Study of Dexpramipexole in ALS (ENVISION)

First Submitted : May 3, 2012
First Submitted that Met QC Criteria : June 14, 2012
First Posted : June 18, 2012 (Estimate)

Certification/Extension First Submitted : November 24, 2014
Certification/Extension First Submitted that Met QC Criteria : November 24, 2014
Certification/Extension First Posted : December 11, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : December 13, 2017
Last Update Posted : December 15, 2017